X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pbt2 (31) 31
index medicus (20) 20
alzheimer's disease (15) 15
humans (14) 14
neurosciences (11) 11
clioquinol - analogs & derivatives (10) 10
copper (10) 10
alzheimers-disease (9) 9
animals (9) 9
zinc (9) 9
a-beta (8) 8
cognition (8) 8
mice (8) 8
clioquinol (7) 7
targeting a-beta (7) 7
transgenic mice (7) 7
8-hydroxyquinoline (6) 6
amyloid beta peptide (6) 6
caenorhabditis elegans (6) 6
clioquinol - therapeutic use (6) 6
protein (6) 6
zinc - metabolism (6) 6
alzheimer disease - metabolism (5) 5
alzheimer’s disease (5) 5
amyloid (5) 5
clioquinol - pharmacology (5) 5
female (5) 5
metals (5) 5
proteins (5) 5
aged (4) 4
alzheimer disease - drug therapy (4) 4
amyloid beta-peptides - metabolism (4) 4
biochemistry & molecular biology (4) 4
brain (4) 4
clinical neurology (4) 4
disease models, animal (4) 4
double-blind (4) 4
male (4) 4
metals - metabolism (4) 4
oxidative stress (4) 4
pbt2 and drug screen (4) 4
placebo-controlled trial (4) 4
toxicity (4) 4
accumulation (3) 3
brain - metabolism (3) 3
cognition disorders - drug therapy (3) 3
copper - metabolism (3) 3
dementia (3) 3
disease (3) 3
hydroxyquinoline (3) 3
in-vitro (3) 3
iron (3) 3
metal (3) 3
pharmacology & pharmacy (3) 3
psychiatry (3) 3
therapeutic (3) 3
aged, 80 and over (2) 2
alzheimer disease - pathology (2) 2
alzheimer disease [drug therapy] (2) 2
alzheimers disease (2) 2
amyloid-beta (2) 2
amyloid-beta-peptide (2) 2
amyotrophic-lateral-sclerosis (2) 2
binding (2) 2
biophysics (2) 2
biotechnology (2) 2
blotting, western (2) 2
brain - pathology (2) 2
c. elegans (2) 2
caenorhabditis-elegans (2) 2
calcineurin (2) 2
cell biology (2) 2
cells, cultured (2) 2
chaperone (2) 2
chelating agents - adverse effects (2) 2
chelating agents - therapeutic use (2) 2
chelating agents [adverse effects; therapeutic use] (2) 2
chemistry, inorganic & nuclear (2) 2
chemistry, medicinal (2) 2
clinical trials randomized controlled (2) 2
clioquinol - administration & dosage (2) 2
clioquinol - adverse effects (2) 2
cohaperone (2) 2
differentiation (2) 2
free radical (2) 2
glutamate (2) 2
hippocampus - drug effects (2) 2
hydrogen-peroxide (2) 2
iron - metabolism (2) 2
long-term potentiation (2) 2
mass spectrometry (2) 2
maze learning - drug effects (2) 2
mechanisms (2) 2
medicine (2) 2
medicine, general & internal (2) 2
memory (2) 2
metals - therapeutic use (2) 2
methyl aspartate (2) 2
mice, inbred balb c (2) 2
mice, knockout (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular Pharmaceutics, ISSN 1543-8384, 02/2018, Volume 15, Issue 2, pp. 695 - 702
Journal Article
JOURNAL OF MEDICINAL CHEMISTRY, ISSN 0022-2623, 11/2015, Volume 58, Issue 22, pp. 8796 - 8805
Neurodegenerative diseases are associated with oxidative stress that is induced by the presence of reactive oxygen species and the abnormal cellular... 
OXIDATIVE STRESS | CHEMISTRY, MEDICINAL | PBT2 | ALZHEIMERS-DISEASE | A-BETA | DOUBLE-BLIND | IRON | PLACEBO-CONTROLLED TRIAL | MANGANESE NEUROTOXICITY | BINDING | TRANSGENIC MICE
Journal Article
Frontiers in Psychiatry, 2012, Volume 3, pp. 15 - 15
As evidence for the role of metal ion dysregulation in the pathogenesis of multiple CNS disorders grows, it has become important to more precisely identify and... 
Cohaperone | Therapeutic | Metal | PBT2 | Alzheimer's disease
Journal Article
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 2010, Volume 20, Issue 2, pp. 509 - 516
Journal Article
Journal Article
Journal of Huntington's Disease, ISSN 1879-6397, 2012, Volume 1, Issue 2, pp. 211 - 219
Background: There is evidence that interaction with biologically important metals, particularly copper and iron, contributes to the pathological aggregation... 
R6/2 | metals | C. elegans | PBT2
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 2014, Volume 42, Issue 4, pp. 1407 - 1413
Journal Article
Frontiers in Psychiatry, 03/2012, Volume 3
As the burden of proof for the role of metal ion dysregulation in the pathogenesis of multiple CNS disorders grows, it has become important to more precisely... 
therapeutic | metal | PBT2 | Alzheimer's disease | Chaperone
Journal Article
Antioxidants & Redox Signaling, ISSN 1523-0864, 09/2017, Volume 27, Issue 9, pp. 567 - 582
Journal Article
Journal Article
Aging Cell, ISSN 1474-9718, 04/2014, Volume 13, Issue 2, pp. 351 - 359
Journal Article
Frontiers in Psychiatry, ISSN 1664-0640, 2012, Volume 3
Journal Article
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, ISSN 0236-5731, 10/2014, Volume 302, Issue 1, pp. 563 - 573
Recently, the development of novel brain imaging agents has aroused much interest thanks to limited number of brain cancer or diseases diagnosis agents. It is... 
CHEMISTRY, ANALYTICAL | Brain imaging | HMPAO | ALZHEIMERS-DISEASE | COMPLEXES | Bioquin | AMYLOID PLAQUES | COGNITION | CHEMISTRY, INORGANIC & NUCLEAR | Tc-99m | NANOPARTICLES | PBT2 | NUCLEAR SCIENCE & TECHNOLOGY | PROGRESS | MICE | BINDING | UTILITY
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.